▲ BUY
6
/ 10
Conviction
$ Value
$300K
Shares
2,400
Price
$125
Filed
Mar 2
▶ Why this score? (6/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
HERON ELAINE J
Title
—
CIK
0001235471
Roles
Director
Transaction Details
Transaction Date
2026-02-27
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
47,812
Footnotes
Represents shares of common stock purchased in the underwritten offering of Palvella Therapeutics, Inc. at the offering price, which closed on February 27, 2026.
Filing Info
HERON ELAINE J's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-27 | PVLA | ▲ | $300K ★ |
| 2025-11-17 | VXRT | ▲ | $9K |
| 2025-11-17 | VXRT | ▲ | $7K |
| 2025-06-13 | VXRT | A | $0 |
| 2025-06-13 | VXRT | A | $0 |
| 2025-06-10 | PVLA | A | $0 |
Other Insiders at PVLA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| JENKINS GEORGE M | $550K | — | 2026-03-30 |
|
Korenberg Matthew E
CFO, Treasurer
|
— | — | 2026-02-05 |
|
Goin Kathleen
Chief Operating Officer
|
— | $1.4M | 2026-04-15 |
| Doux John | — | — | 2026-04-13 |
|
Martini Jeffrey S
Chief Scientific Officer
|
— | — | 2026-02-05 |
|
Kaupinen Wes
President and CEO
|
— | — | 2026-02-05 |
|
Kline Ashley Hartmann
Chief Commercial Officer
|
— | — | 2026-02-05 |